USD 5.69
↑ 0.12 (2.15%)
| ticker | 1 day return % | 1 week return % | 1 month return % | 3 months return % | 6 months return % | 1 year return % | 3 years return % | 5 years return % | 10 years return % | maximum return % |
|---|---|---|---|---|---|---|---|---|---|---|
| AVAH | 2.2 | -2.7 | 6.4 | 14.5 | 113.9 | 158.6 | -23.8 | -52.6 | -52.6 | -52.6 |
| S&P 500 | 0.4 | -1.5 | 0.5 | 6.1 | 11.1 | 29.6 | 25.3 | 88.8 | 187.2 | 33272.7 |
Our interactive price chart includes various drawing tools to help you analyze the product more effectively. Below is a quick guide on how to use these tools: Full Guideline
Feel free to experiment with these tools to enhance your technical analysis. Remember, any drawings you make are temporary and will be lost upon refreshing the page unless saved as an image using the 'Camera' icon.
Get instant AI-powered professional insights on prices:
💡Generate AI Technical Analysis ReportA Multi-Interval Candlestick Chart displays the price movements of an asset over different time intervals. Each candlestick represents the open, high, low, and close prices for a specific interval. The chart can be used to identify trends and patterns in price movements.
| Attribute | Value |
|---|---|
| symbol | AVAH |
| name | Aveanna Healthcare Holdings Inc. |
| price | 5.69 |
| changes percentage | 2.15 |
| change | 0.12 |
| day low | 5.57 |
| day high | 5.74 |
| year high | 6.19 |
| year low | 2 |
| market cap | 1099450250 |
| price avg 50 | 5.15 |
| price avg 200 | 3.56 |
| exchange | NASDAQ |
| volume | 192480 |
| avg volume | 317637 |
| open | 5.58 |
| previous close | 5.57 |
| eps | -0.35 |
| pe | -16.26 |
| earnings announcement | 2025-03-13T04:00:00.000+0000 |
| shares outstanding | 193225000 |
| timestamp | 2024-11-18 21:00:01 |
We derive the score of a company's financial statements by evaluating the weighted average sentiment across key within the statements. The cumulative score, normalized to a sum of 1, serves as a metric for assessing the company's performance during the specified period. A higher score indicates stronger performance. However, it's crucial to note that while this score provides valuable insights, it is just one of many factors to consider when making informed investment decisions. A holistic evaluation, considering various aspects of the company's financial health and market conditions, is essential for a well-rounded investment strategy.
| 2023 | 2022 | Y/Y change % | |
|---|---|---|---|
| 0001832332 | |||
| revenue | 1895209000 | 1787645000 | 6.02 |
| gross profit | 595432000 | 553227000 | 7.63 |
| gross profit ratio | 0.31 | 0.31 | 1.52 |
| research and development expenses | 0 | 0 | NaN |
| operating expenses | 587360000 | 520058000 | 12.94 |
| interest income | 327000 | 679000 | -51.84 |
| interest expense | 153246000 | 99940000 | 53.34 |
| ebitda | 44348000 | -517277999 | 108.57 |
| ebitdaratio | 0.02 | 0.04 | -35.76 |
| operating income | 8072000 | 26305000 | -69.31 |
| operating income ratio | 0.0 | 0.01 | -71.06 |
| net income | -134524000 | -662034000 | 79.68 |
| net income ratio | -0.07 | -0.37 | 80.83 |
| eps | -0.71 | -3.57 | 80.11 |
Revenue Growth: revenue increased to 1,895 million in 2023 from 1,788 million in 2022 representing a change of 6.02%. This indicates a sales growth, which is a positive sign for the company.
Gross Profit: Gross Profit increased to 595 million in 2023 from 553 million in 2022 representing a change of 7.63%. This indicates a sales profitability growth, which is a positive sign for the company.
EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) increased to 44 million in 2023 from -517 million in 2022 representing a change of 108.57%. The increase in EBITDA indicates improved operational efficiency and profitability.
Operating Income: Operating income increased to 8 million in 2023 from 26 million in 2022 representing a change of -69.31%. The increase in operating income indicates better operational performance and increased profitability.
Earnings per Share (EPS): EPS increased to -0.71 in 2023 from -0.71 in 2022 representing a change of 80.11%. This indicates that the company's earnings are increasing and it is becoming more profitable on a per-share basis.
Operating Expenses: Operating Expenses increased to 587 million in 2023 from 520 million in 2022 representing a change of 12.94%. The increase in operating expenses can be attributed to various factors such as marketing, administrative costs, and investments in infrastructure. It's important to monitor if these expenses are growing at a sustainable rate compared to revenue.
Net Income: Net income decreased to -135 million in 2023 from -662 million in 2022 representing a change of 79.68%. The decrease in net income shows worsen profitability and indicates that the company is generating less profit for each dollar of revenue.
| 2024Q3 | 2024Q2 | Q/Q change % | |
|---|---|---|---|
| 0001832332 | |||
| revenue | 509023000 | 504958000 | 0.81 |
| gross profit | 159699000 | 155434000 | 2.74 |
| gross profit ratio | 0.31 | 0.31 | 1.92 |
| research and development expenses | 0 | 0 | NaN |
| operating expenses | 125675000 | 116226000 | 8.13 |
| interest income | 100000 | 95000 | 5.26 |
| interest expense | 39245000 | 39613000 | -0.93 |
| ebitda | 19261000 | 51059000 | -62.28 |
| ebitdaratio | 0.04 | 0.09 | -59.06 |
| operating income | 34024000 | 39208000 | -13.22 |
| operating income ratio | 0.07 | 0.08 | -13.91 |
| net income | -42843000 | 13906000 | -408.09 |
| net income ratio | -0.08 | 0.03 | -405.63 |
| eps | -0.22 | 0.07 | -404.71 |
Revenue Growth: revenue increased to 509 million in 2024Q3 from 505 million in 2024Q2 representing a change of 0.81%. This indicates a sales growth, which is a positive sign for the company.
Gross Profit: Gross Profit increased to 160 million in 2024Q3 from 155 million in 2024Q2 representing a change of 2.74%. This indicates a sales profitability growth, which is a positive sign for the company.
Operating Expenses: Operating Expenses increased to 126 million in 2024Q3 from 116 million in 2024Q2 representing a change of 8.13%. The increase in operating expenses can be attributed to various factors such as marketing, administrative costs, and investments in infrastructure. It's important to monitor if these expenses are growing at a sustainable rate compared to revenue.
EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) decreased to 19 million in 2024Q3 from 51 million in 2024Q2 representing a change of -62.28%. The decrease in EBITDA indicates declined operational efficiency and profitability.
Operating Income: Operating income decreased to 34 million in 2024Q3 from 39 million in 2024Q2 representing a change of -13.22%. The decrease in operating income indicates worse operational performance and decreased profitability.
Net Income: Net income decreased to -43 million in 2024Q3 from 14 million in 2024Q2 representing a change of -408.09%. The decrease in net income shows worsen profitability and indicates that the company is generating less profit for each dollar of revenue.
Earnings per Share (EPS): EPS increased to -0.22 in 2024Q3 from -0.22 in 2024Q2 representing a change of -404.71%. This indicates that the company's earnings are decreasing and it is becoming less profitable on a per-share basis.
| 2023 | 2022 | Y/Y change % | |
|---|---|---|---|
| 0001832332 | |||
| total assets | 1612985000 | 1711760000 | -5.77 |
| total liabilities | 1740420000 | 1715935000 | 1.43 |
| total equity | -127435000 | -4175000 | -2,952.34 |
| cash and cash equivalents | 43942000 | 19217000 | 128.66 |
| short term investments | 0 | 0 | NaN |
| long term investments | 74815000 | 104665000 | -28.52 |
| total current assets | 314886000 | 269751000 | 16.73 |
| total non current assets | 1298099000 | 1442009000 | -9.98 |
| total current liabilities | 354758000 | 326497000 | 8.66 |
| total non current liabilities | 1385662000 | 1389438000 | -0.27 |
| common stock | 1907000 | 1888000 | 1.01 |
| retained earnings | -1371234000 | -1236710000 | -10.88 |
| total debt | 1499195000 | 1355345000 | 10.61 |
Total Assets: Total Assets decreased to 1,613 million in 2023 from 1,712 million in 2022 representing a change of -5.77%. Suggesting a decrease in asset holdings.
Total Liabilities: Total Liabilities increased to 1,740 million in 2023 from 1,716 million in 2022 representing a change of 1.43%. This indicates an increase in overall liabilities.
Total Equity: Total Equity decreased to -127 million in 2023 from -4 million in 2022 representing a change of -2952.34%. This indicates a decrease in shareholders' equity.
Total Current Liabilities: Total Current Liabilities increased to 355 million in 2023 from 326 million in 2022 representing a change of 8.66%. This indicates a higher short-term debt burden.
Retained Earnings: Retained Earnings decreased to -1,371 million in 2023 from -1,237 million in 2022 representing a change of -10.88%. This indicates an accumulated losses.
Total Debt: Total Debt increased to 1,499 million in 2023 from 1,355 million in 2022 representing a change of 10.61%. This indicates an increase in overall debt burden.
Cash And Cash Equivalents: Cash And Cash Equivalents increased to 44 million in 2023 from 19 million in 2022 representing a change of 128.66%. This indicates an increase in available liquid assets.
Total Current Assets: Total Current Assets increased to 315 million in 2023 from 270 million in 2022 representing a change of 16.73%. This indicates a better liquidity position.
Common Stock: Common Stock increased to 2 in 2023 from 2 in 2022 representing a change of 1.01%. This indicates an increase in ownership interest.
| 2024Q3 | 2024Q2 | Q/Q change % | |
|---|---|---|---|
| 0001832332 | |||
| total assets | 1644166000 | 1664465000 | -1.22 |
| total liabilities | 1799147000 | 1781972000 | 0.96 |
| total equity | -154981000 | -118968000 | -30.27 |
| cash and cash equivalents | 78462000 | 47661000 | 64.63 |
| short term investments | 0 | 0 | NaN |
| long term investments | 0 | 82599000 | -100.00 |
| total current assets | 381366000 | 364004000 | 4.77 |
| total non current assets | 1262800000 | 1300460999 | -2.90 |
| total current liabilities | 406036000 | 389146000 | 4.34 |
| total non current liabilities | 1393111000 | 1392826000 | 0.02 |
| common stock | 0 | 1924000 | -100.00 |
| retained earnings | -1411343000 | -1368500000 | -3.13 |
| total debt | 1333071000 | 1504689000 | -11.41 |
Total Assets: Total Assets decreased to 1,644 million in 2024Q3 from 1,664 million in 2024Q2 representing a change of -1.22%. Suggesting a decrease in asset holdings.
Total Liabilities: Total Liabilities increased to 1,799 million in 2024Q3 from 1,782 million in 2024Q2 representing a change of 0.96%. This indicates an increase in overall liabilities.
Total Equity: Total Equity decreased to -155 million in 2024Q3 from -119 million in 2024Q2 representing a change of -30.27%. This indicates a decrease in shareholders' equity.
Total Current Liabilities: Total Current Liabilities increased to 406 million in 2024Q3 from 389 million in 2024Q2 representing a change of 4.34%. This indicates a higher short-term debt burden.
Common Stock: Common Stock decreased to 0 in 2024Q3 from 2 in 2024Q2 representing a change of -100.0%. This indicates a decrease in ownership interest.
Retained Earnings: Retained Earnings decreased to -1,411 million in 2024Q3 from -1,368 million in 2024Q2 representing a change of -3.13%. This indicates an accumulated losses.
Cash And Cash Equivalents: Cash And Cash Equivalents increased to 78 million in 2024Q3 from 48 million in 2024Q2 representing a change of 64.63%. This indicates an increase in available liquid assets.
Total Current Assets: Total Current Assets increased to 381 million in 2024Q3 from 364 million in 2024Q2 representing a change of 4.77%. This indicates a better liquidity position.
Total Debt: Total Debt decreased to 1,333 million in 2024Q3 from 1,505 million in 2024Q2 representing a change of -11.41%. This indicates a reduction in overall debt burden.
| 2023 | 2022 | Y/Y change % | |
|---|---|---|---|
| 0001832332 | |||
| net change in cash | 24725000 | -11273000 | 319.33 |
| operating cash flow | 22672000 | -48402000 | 146.84 |
| free cash flow | 16556000 | -60415000 | 127.40 |
| capital expenditure | -6116000 | -12013000 | 49.09 |
| depreciation and amortization | 30098000 | 38816000 | -22.46 |
| deferred income tax | 1014999 | -115000 | 982.61 |
| stock based compensation | 0 | 15893000 | -100.00 |
| accounts payables | -13920000 | -3925000 | -254.65 |
| inventory | 0 | 0 | NaN |
| acquisitions net | 0 | -1553000 | 100.00 |
| investments in property plant and equipment | -6116000 | -12013000 | 49.09 |
| net cash used for investing activites | -8794000 | -25291000 | 65.23 |
| debt repayment | -4683000 | 60149000 | -107.79 |
| common stock issued | 945000 | 4014999 | -76.46 |
| common stock repurchased | 0 | 0 | NaN |
| dividends paid | 0 | 0 | NaN |
| net cash used provided by financing activities | 10847000 | 62420000 | -82.62 |
| cash at end of period | 43942000 | 19217000 | 128.66 |
| accounts receivables | 0 | -3227000 | 100.00 |
| cash at beginning of period | 19217000 | 30490000 | -36.97 |
Net Change in Cash: Net Change in Cash increased to 25 million in 2023 from -11 million in 2022 representing a change of 319.33%. Indicating an increased ability to generate cash from the company's operations or its cash flow position.
Operating Cash Flow: Operating Cash Flow increased to 23 million in 2023 from -48 million in 2022 representing a change of 146.84%. This indicates that the company generated more cash from its core business operations.
Free Cash Flow: Free Cash Flow increased to 17 million in 2023 from -60 million in 2022 representing a change of 127.4%. This indicates an increase in cash generated after accounting for capital expenditures.
Stock-Based Compensation: Stock-Based Compensation decreased to 0 million in 2023 from 16 million in 2022 representing a change of -100.0%. This indicates decreased expenses, which is generally considered a positive sign from a financial perspective.
Capital Expenditure: Capital Expenditure increased to -6 million in 2023 from -12 million in 2022 representing a change of 49.09%. This indicates an increase in the cash outflow required for acquiring or improving long-term assets.
Deferred Income Tax: Deferred Income Tax increased to 1 million in 2023 from 0 million in 2022 representing a change of 982.61%. This indicates that the company's tax liability for future periods has increased.
Accounts Payables: The absolute value of Accounts Payables increased to 14 million in 2023 from 4 million in 2022 representing a change of -254.65%. This indicates that the company has increased its outstanding obligations to its suppliers.
Accounts Receivables: Accounts Receivables increased to 0 in 2023 from -3 million in 2022 representing a change of 100.0%. This suggests that the company is less capable of collecting payments from its customers.
| 2024Q3 | 2024Q2 | Q/Q change % | |
|---|---|---|---|
| 0001832332 | |||
| operating cash flow | 29394000 | 1809000 | 1,524.88 |
| free cash flow | 27181000 | 540000 | 4,933.52 |
| capital expenditure | -2213000 | -1269000 | -74.39 |
| depreciation and amortization | 7348000 | 7467000 | -1.59 |
| deferred income tax | -84000 | -3000 | -2,700.00 |
| stock based compensation | 4902000 | 3500000 | 40.06 |
| accounts receivables | 7513000 | 0 | NaN |
| accounts payables | 3557000 | -4703000 | 175.63 |
| inventory | 0 | 0 | NaN |
| acquisitions net | 0 | 0 | NaN |
| investments in property plant and equipment | -2213000 | -1269000 | -74.39 |
| net cash used for investing activites | -2213000 | -1269000 | -74.39 |
| debt repayment | -1110000 | 456000 | -343.42 |
| common stock issued | 0 | 0 | NaN |
| common stock repurchased | 0 | 0 | NaN |
| dividends paid | 0 | 0 | NaN |
| net cash used provided by financing activities | 3620000 | 4514000 | -19.81 |
| net change in cash | 30801000 | 5054000 | 509.44 |
| cash at end of period | 78462000 | 47661000 | 64.63 |
| cash at beginning of period | 47661000 | 42607000 | 11.86 |
Net Change in Cash: Net Change in Cash increased to 31 million in 2024Q3 from 5 million in 2024Q2 representing a change of 509.44%. Indicating an increased ability to generate cash from the company's operations or its cash flow position.
Operating Cash Flow: Operating Cash Flow increased to 29 million in 2024Q3 from 2 million in 2024Q2 representing a change of 1524.88%. This indicates that the company generated more cash from its core business operations.
Free Cash Flow: Free Cash Flow increased to 27 million in 2024Q3 from 1 million in 2024Q2 representing a change of 4933.52%. This indicates an increase in cash generated after accounting for capital expenditures.
Capital Expenditure: Capital Expenditure decreased to -2 million in 2024Q3 from -1 million in 2024Q2 representing a change of -74.39%. This indicates a possible improved efficiency or a shift in the company's strategic priorities.
Accounts Payables: The absolute value of Accounts Payables decreased to 4 million in 2024Q3 from 5 million in 2024Q2 representing a change of 175.63%. This indicates that the company has reduced its outstanding obligations to its suppliers.
Stock-Based Compensation: Stock-Based Compensation increased to 5 million in 2024Q3 from 4 million in 2024Q2 representing a change of 40.06%. This indicates increased expenses, which is generally considered a negative sign from a financial perspective.
Accounts Receivables: Accounts Receivables increased to 8 in 2024Q3 from 0 million in 2024Q2 representing a change of nan%. This suggests that the company is less capable of collecting payments from its customers.
We save you time by utilizing Generative AI to summarize earnings transcripts. Our summaries provide a clear insight into the company's current performance, future outlook, and overall sentiment expressed during the call. Click on below links to explore more.
Note: The years mentioned below are fiscal years in accounting.
Q3 2024 Earnings call transcript
EPS represents the portion of a company's profit allocated to each outstanding share of common stock. A higher EPS is generally favorable, indicating stronger profitability on a per-share basis.
Positive EPS: A positive EPS signifies that a company is profitable, it is generally viewed positively, supporting stock value and investor confidence.
Negative EPS: Indicates that a company is operating at a loss, which could lead to negative sentiment, potential stock depreciation, and concerns about the company's financial health.
The Next Earning Date represents when the company plans to release its next set of financial results.
An upward trend in EPS suggests consistent growth in earnings, often leading to increased investor confidence. A downward trend may indicate a decline in earnings, potentially decreasing investor confidence and stock value. Fluctuating EPS suggests unpredictable financial performance, warranting cautious investor analysis.
Earnings surprise occurs when a company's actual earnings differ from analysts' expectations. A positive earnings surprise typically reflects better-than-expected performance, potentially leading to stock appreciation. Conversely, a negative earnings surprise can result in stock depreciation. An earnings surprise of zero means the earnings met expectations, which typically has a neutral impact on stock price.
Discover detailed analyst recommendations for stocks, including categories such as Buy, Hold, Sell, Strong Buy, and Strong Sell. These insights are based on thorough analysis of financial and market factors. The consensus is calculated by assigning a numerical score to each recommendation. These scores are then weighted and averaged over a specified period to provide a comprehensive view of the stock's outlook, with the final score determining the overall consensus.
| 2023-12-30 | 2022-12-31 | Y/Y change % | |
|---|---|---|---|
| FY | |||
| calendar year | 2023 | 2022 | NaN |
| revenue per share | 9.98 | 9.63 | 3.56 |
| net income per share | -0.71 | -3.57 | 80.15 |
| operating cash flow per share | 0.12 | -0.26 | 145.76 |
| free cash flow per share | 0.09 | -0.33 | 126.77 |
| cash per share | 0.23 | 0.1 | 123.36 |
| book value per share | -0.67 | -0.02 | -2,881.59 |
| tangible book value per share | -6.72 | -6.79 | 1.06 |
| shareholders equity per share | -0.67 | -0.02 | -2,881.59 |
| interest debt per share | 8.41 | 8.28 | 1.58 |
| market cap | 509082080.0 | 144731340 | 251.74 |
| enterprise value | 1964335080 | 1480859340 | 32.65 |
| pe ratio | -3.78 | -0.22 | -1,631.03 |
| price to sales ratio | 0.27 | 0.08 | 231.78 |
| pocfratio | 22.45 | -2.99 | 850.93 |
| pfcf ratio | 30.75 | -2.4 | 1,383.56 |
| pb ratio | -3.99 | -34.67 | 88.48 |
| ptb ratio | -3.99 | -34.67 | 88.48 |
| ev to sales | 1.04 | 0.83 | 25.12 |
| enterprise value over ebitda | 44.29 | -2.86 | 1,647.22 |
| ev to operating cash flow | 86.64 | -30.6 | 383.19 |
| ev to free cash flow | 118.65 | -24.51 | 584.05 |
| earnings yield | -0.26 | -4.57 | 94.22 |
| free cash flow yield | 0.03 | -0.42 | 107.79 |
| debt to equity | -11.34 | -344.06 | 96.71 |
| debt to assets | 0.9 | 0.84 | 6.72 |
| net debt to ebitda | 32.81 | -2.58 | 1,370.40 |
| current ratio | 0.89 | 0.83 | 7.43 |
| interest coverage | 0.05 | 0.26 | -79.99 |
| income quality | -0.17 | 0.07 | -330.52 |
| dividend yield | 0 | 0 | NaN |
| payout ratio | 0 | 0 | NaN |
| sales general and administrative to revenue | 0.25 | 0.27 | -9.42 |
| research and ddevelopement to revenue | 0 | 0 | NaN |
| intangibles to total assets | 0.71 | 0.73 | -2.92 |
| capex to operating cash flow | 0.27 | -0.25 | 208.69 |
| capex to revenue | 0.0 | 0.01 | -51.98 |
| capex to depreciation | 0.2 | 0.31 | -34.34 |
| stock based compensation to revenue | 0 | 0.01 | -100.00 |
| graham number | 3.27 | 1.34 | 143.27 |
| roic | 0.01 | 0.02 | -67.62 |
| return on tangible assets | -0.29 | -1.45 | 80.04 |
| graham net net | -7.96 | -8.19 | 2.82 |
| working capital | -39872000 | -56746000 | 29.74 |
| tangible asset value | -1275997000 | -1259726000 | -1.29 |
| net current asset value | -1425534000 | -1446184000 | 1.43 |
| invested capital | 1178737000 | 1276158000 | -7.63 |
| average receivables | 235720000 | 225461000 | 4.55 |
| average payables | 37377000 | 48624000 | -23.13 |
| average inventory | 7544500 | 14661000 | -48.54 |
| days sales outstanding | 47.34 | 46.07 | 2.76 |
| days payables outstanding | 8.46 | 13.19 | -35.88 |
| days of inventory on hand | 0 | 4.46 | -100.00 |
| receivables turnover | 7.71 | 7.92 | -2.68 |
| payables turnover | 43.14 | 27.66 | 55.95 |
| inventory turnover | 0 | 81.81 | -100.00 |
| roe | 1.06 | 158.57 | -99.33 |
| capex per share | 0.03 | 0.06 | -50.27 |
ROE: Return on Equity (ROE) decreased to 1.06 on 2023-12-30 from 158.57 on 2022-12-31, representing a change of -99.33%. However, ROE is >= 15%, suggesting that the company has been generating high returns for its shareholders still.
Debt-to-Equity Ratio: Debt-to-Equity Ratio increased to -11.34 on 2023-12-30 from -344.06 on 2022-12-31, representing a change of 96.71%. The debt-to-equity ratio has been increasing, indicating that the company has been relying more on debt financing. Higher leverage may increase financial risk. However, a ratio of 1 or below is often considered healthy and indicates that the company's total debt is equal to or less than its total equity.
PE Ratio: Price-to-Earnings (P/E) Ratio decreased to -3.78 on 2023-12-30 from -0.22 on 2022-12-31, representing a change of -1631.03%. Indicating a decrease in the relative valuation of the company's stock.
Current Ratio: Current Ratio increased to 0.89 on 2023-12-30 from 0.83 on 2022-12-31, representing a change of 7.43%. The current ratio has been increasing, suggesting an increase in the company's short-term liquidity. However, it's below 1, indicating potential liquidity issues.
| 2024-09-28 Q3 | 2024-06-29 Q2 | Q/Q change % | |
|---|---|---|---|
| AVAH | |||
| calendar year | 2024 | 2024 | NaN |
| revenue per share | 2.63 | 2.62 | 0.41 |
| net income per share | -0.22 | 0.07 | -406.88 |
| operating cash flow per share | 0.15 | 0.01 | 1,518.48 |
| free cash flow per share | 0.14 | 0.0 | 4,913.71 |
| cash per share | 0.41 | 0.25 | 63.98 |
| book value per share | -0.8 | -0.61 | -31.37 |
| tangible book value per share | -6.72 | -6.57 | -2.31 |
| shareholders equity per share | -0.8 | -0.62 | -29.76 |
| interest debt per share | 7.1 | 7.75 | -8.43 |
| market cap | 999676370 | 531576000.0 | 88.06 |
| enterprise value | 2254285370 | 1988604000 | 13.36 |
| pe ratio | -5.83 | 9.56 | -161.04 |
| price to sales ratio | 1.96 | 1.05 | 86.56 |
| pocfratio | 34.01 | 293.85 | -88.43 |
| pfcf ratio | 36.78 | 984.4 | -96.26 |
| pb ratio | -6.45 | -4.47 | -44.36 |
| ptb ratio | -6.45 | -4.47 | -44.36 |
| ev to sales | 4.43 | 3.94 | 12.45 |
| enterprise value over ebitda | 117.04 | 38.95 | 200.51 |
| ev to operating cash flow | 76.69 | 1099.28 | -93.02 |
| ev to free cash flow | 82.94 | 3682.6 | -97.75 |
| earnings yield | -0.04 | 0.03 | -263.83 |
| free cash flow yield | 0.03 | 0.0 | 2,576.56 |
| debt to equity | -8.6 | -12.21 | 29.58 |
| debt to assets | 0.81 | 0.87 | -7.13 |
| net debt to ebitda | 65.14 | 28.54 | 128.26 |
| current ratio | 0.94 | 0.94 | 0.41 |
| interest coverage | 0.87 | 0.99 | -12.41 |
| income quality | -0.69 | 0.13 | -627.40 |
| dividend yield | 0 | 0 | NaN |
| payout ratio | 0 | 0 | NaN |
| sales general and administrative to revenue | 0.23 | 0.23 | 0.66 |
| research and ddevelopement to revenue | 0 | 0 | NaN |
| intangibles to total assets | 0.7 | 0.69 | 0.96 |
| capex to operating cash flow | 0.08 | 0.7 | -89.27 |
| capex to revenue | 0.0 | 0.0 | 73.00 |
| capex to depreciation | 0.3 | 0.17 | 77.21 |
| stock based compensation to revenue | 0.01 | 0.01 | 38.94 |
| graham number | 2.0 | 1.0 | 99.55 |
| roic | 0.05 | 0.1 | -55.92 |
| return on tangible assets | -0.09 | 0.03 | -418.68 |
| graham net net | -7.87 | -7.9 | 0.33 |
| working capital | -24670000 | -25142000 | 1.88 |
| tangible asset value | -1299279000 | -1264918000 | -2.72 |
| net current asset value | -1417781000 | -1417968000 | 0.01 |
| invested capital | 1180214000 | 1187258999 | -0.59 |
| average receivables | 275201000 | 276760500 | -0.56 |
| average payables | 40521000 | 41146000 | -1.52 |
| average inventory | 0 | 1 | -100.00 |
| days sales outstanding | 46.93 | 50.79 | -7.59 |
| days payables outstanding | 10.8 | 10.07 | 7.24 |
| days of inventory on hand | 0 | 0 | NaN |
| receivables turnover | 1.92 | 1.77 | 8.21 |
| payables turnover | 8.33 | 8.94 | -6.75 |
| inventory turnover | 0 | 0 | NaN |
| roe | 0.28 | -0.12 | 336.50 |
| capex per share | 0.01 | 0.01 | 73.70 |
ROE: Return on Equity (ROE) increased to 0.28 on 2024-09-28 Q3 from -0.12 on 2024-06-29 Q2, representing a change of 336.50%. Suggesting the company has been generating high returns for its shareholders.
PE Ratio: Price-to-Earnings (P/E) Ratio decreased to -5.83 on 2024-09-28 Q3 from 9.56 on 2024-06-29 Q2, representing a change of -161.04%. Indicating a decrease in the relative valuation of the company's stock.
Current Ratio: Current Ratio decreased to 0.94 on 2024-09-28 Q3 from 0.94 on 2024-06-29 Q2, representing a change of 0.41%. The current ratio has been declining, suggesting a decrease in the company's short-term liquidity. Also, it's below 1, indicating potential liquidity issues.
Debt-to-Equity Ratio: Debt-to-Equity Ratio increased to -8.60 on 2024-09-28 Q3 from -12.21 on 2024-06-29 Q2, representing a change of 29.58%. The debt-to-equity ratio has been increasing, indicating that the company has been relying more on debt financing. Higher leverage may increase financial risk. However, a ratio of 1 or below is often considered healthy and indicates that the company's total debt is equal to or less than its total equity.
None
| Market Capitalization | Enterprise Value | |
|---|---|---|
| Definition | The total market value of a company's outstanding shares | The total market value of a company, including its debt and other liabilities |
| Calculation | Current share price * Total number of outstanding shares | Market capitalization + Total debt - Cash and cash equivalents |
| Focus | Equity component of a company's value | Total economic value of a company |
| Usefulness | Assesses a company's size and growth potential based on investor sentiment | Provides a more comprehensive valuation that considers both equity and debt |
Analyzing dividends is a crucial aspect of investment evaluation, offering valuable insights into a company's financial health and its commitment to shareholder returns. Dividends represent a portion of a company's profits distributed to its shareholders, providing a steady income stream. We help you analyze dividends based on the indicators mentioned below:
• Investors often assess the average dividend amount, observing trends over time to gauge the company's stability and growth potential. A positive trend in average dividends indicates a consistent and potentially lucrative investment. Additionally, evaluating the trend of dividend increases provides insight into the company's financial strength and management's confidence in future earnings.
• Consistency in paying dividends is a reassuring sign, reflecting a company's reliability and commitment to shareholder value. For investors, dividends not only offer income but also contribute to the overall total return on investment.
• Companies with a history of regular and increasing dividends can attract income-focused investors seeking stable returns, making dividends a critical factor in building a well-rounded investment portfolio.
Interested in the overall sentiment for a particular period? Check out our news sentiment analysis tool.
Sentiment: Positive
Publish Date: 2024-11-08 21:36:33
Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH ) Q3 2024 Earnings Conference Call November 7, 2024 10:00 AM ET Company Participants Debbie Stewart - Chief Accounting Officer Jeff Shaner - Chief Executive Officer Matt Buckhalter - Chief Financial Officer Conference Call Participants Ben Hendrix - RBC Capital Markets Pito Chickering - Deutsche Bank Brian Tanquilut - Jefferies Grayson McAlister - Truist Securities Operator Good morning, and welcome to the Aveanna Healthcare Holdings Third Quarter 2024 Earnings Conference Call. Today's call is being recorded and we have allocated one hour for prepared remarks and Q&A.
Sentiment: Positive
Publish Date: 2024-11-07 10:36:12
Although the revenue and EPS for Aveanna (AVAH) give a sense of how its business performed in the quarter ended September 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Sentiment: Negative
Publish Date: 2024-11-07 08:50:37
Aveanna Healthcare (AVAH) came out with quarterly earnings of $0.02 per share, beating the Zacks Consensus Estimate of a loss of $0.01 per share. This compares to loss of $0.03 per share a year ago.
Sentiment: Positive
Publish Date: 2024-11-07 06:30:00
ATLANTA, Nov. 07, 2024 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. (NASDAQ: AVAH), a leading, diversified home care platform focused on providing care to medically complex, high-cost patient populations, today announced financial results for the three and nine-month periods September 28, 2024.
Sentiment: Positive
Publish Date: 2024-11-04 07:30:00
ATLANTA, Nov. 04, 2024 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. (NASDAQ: AVAH), a leading, diversified home care platform focused on providing care to medically complex, high-cost patient populations, today announced the appointment of Brent Layton to serve as a Class III director of the Board of Directors of Aveanna Healthcare Holdings Inc., and additionally as a member of the Audit Committee of the Board, effective November 1, 2024.
Sentiment: Positive
Publish Date: 2024-10-25 07:51:08
KGC, ORLA, CVNA, CAVA and AVAH have been added to the Zacks Rank #1 (Strong Buy) List on October 25, 2024.
Sentiment: Neutral
Publish Date: 2024-10-21 07:30:00
ATLANTA, Oct. 21, 2024 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. (“Aveanna”) (NASDAQ: AVAH) today announced that its management team will attend the Stephens Annual Investment Conference. Management will host virtual 1x1 investor meetings on Friday, November 22, 2024.
Sentiment: Neutral
Publish Date: 2024-10-17 06:30:00
ATLANTA, Oct. 17, 2024 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. (“Aveanna”) (NASDAQ: AVAH) today announced that the company will release its third quarter results before the market open on Thursday, November 7, 2024, to be followed by a conference call at 10:00 a.m. (Eastern Time) on the same day.
Sentiment: Neutral
Publish Date: 2024-10-11 10:40:22
Here is how Aveanna Healthcare (AVAH) and Cardinal Health (CAH) have performed compared to their sector so far this year.
Sentiment: Positive
Publish Date: 2024-09-26 13:01:27
Does Aveanna Healthcare (AVAH) have what it takes to be a top stock pick for momentum investors? Let's find out.
Sentiment: Positive
Publish Date: 2024-09-26 09:51:22
If you are looking for stocks that have gained strong momentum recently but are still trading at reasonable prices, Aveanna (AVAH) could be a great choice. It is one of the several stocks that passed through our 'Fast-Paced Momentum at a Bargain' screen.
Sentiment: Neutral
Publish Date: 2024-09-20 10:41:39
Here is how Aveanna Healthcare (AVAH) and AxoGen (AXGN) have performed compared to their sector so far this year.
Sentiment: Neutral
Publish Date: 2024-09-10 07:00:00
ATLANTA, Sept. 10, 2024 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. (“Aveanna”) (NASDAQ: AVAH) today announced that its management team will attend the Deutsche Bank Annual Leveraged Finance Conference in Scottsdale, AZ on September 24, 2024. Management will host 1x1 investor meetings that day.
Sentiment: Positive
Publish Date: 2024-09-05 09:50:49
Aveanna (AVAH) could be a great choice for investors looking to buy stocks that have gained strong momentum recently but are still trading at reasonable prices. It is one of the several stocks that made it through our 'Fast-Paced Momentum at a Bargain' screen.
Sentiment: Positive
Publish Date: 2024-09-02 10:45:59
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Sentiment: Positive
Publish Date: 2024-08-28 09:10:41
AVAH stock has the potential to continue its uptrend on the back of a better payer rate environment and its focus on high-paying customers.
* The sentiment analysis presented is generated through an algorithm and may be subject to inaccuracies. Users are advised to corroborate key information and employ further analytical methods prior to making critical decisions.
Get instant AI-powered professional insights:
💡Generate AI Technical Analysis ReportUnderstand the chart below:
Interpret Technical Indicators
| Indicator | Bullish | Bearish |
|---|---|---|
| Price and EMA ⓘ | Price crosses above EMA | Price crosses below EMA |
| Short-Term vs Long-Term EMA ⓘ | Short EMA crosses above Long EMA | Short EMA crosses below Long EMA |
| Volume ⓘ | Increasing volume during price uptrend | Increasing volume during price downtrend |
| MACD ⓘ | MACD crosses above Signal Line | MACD crosses below Signal Line |
| RSI ⓘ | RSI is below 30 (oversold) and starts to rise above 30 | RSI is above 70 (overbought) and starts to decline below 70 |
| Candlestick Patterns ⓘ | Bullish candlestick patterns | Bearish candlestick patterns |
Copyright © 2024 Sirius Investors
All rights reserved
